Fear of Recurrence and Stopping Immunotherapy

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
University of Pittsburgh
Study ID
NCT04761328
Status
Recruiting
Apply to this trial

Conditions

  • Cognitive Behavioral Therapy

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • cognitive behavioral therapy — BEHAVIORAL
    Cognitive-behavioral therapy involves changing these erroneous cognitions and beliefs through cognitive restructuring, modification of behavior, and development of alternative coping skills.

Study Details

The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.

Key Dates

Start date
Aug 2, 2021
Status verified
Dec 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2028

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Cessation of treatment
    If the patient is randomized to this arm, they will be asked to stop their immunotherapy

Primary Outcome Measure

Reduce fear of recurrence [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UPMC Hillman Cancer CentersPittsburghPennsylvania15213
Jennifer L Steel, Ph.D.
[email protected]
412-692-2041

Find similar trials in Pittsburgh, PA

By research site
UPMC Hillman Cancer Centers· Pittsburgh, PA

Related Studies